Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT
Jesus Ruiz‐Ramos,Aitor Alquézar‐Arbé,Ana Juanes‐Borrego,Juan González‐del‐Castillo,Javier Jacob,Guillermo Burillo,Sira Aguiló,Cesáreo Fernandez,Adrián Plaza‐Díaz,Javier Millán‐Soria,Gema Jara‐Torres,Nieves López‐Delmas,Esperanza Muñoz‐Triano,Cristina Martín‐Durán,Violeta Delgado‐Sardina,Blanca Andrea Gallardo‐Sánchez,Ivet Gina Osorio‐Quispe,Antonio Real‐López,Susana Gordo‐Remartinez,Lucía González‐Ferreira,Alberto Álvarez‐Madrigal,Julia Martínez‐Ibarreta‐Zorita,María Sánchez‐Moreno,Maite Sanchez‐Moreno,Jesús Ángel Sánchez‐Serrano,Raquel Hernando‐Fernández,Jennifer Turcios‐Torres,Paola Ponte‐Márquez,Òscar Miró
DOI: https://doi.org/10.1002/pds.70044
2024-10-31
Pharmacoepidemiology and Drug Safety
Abstract:Aim Benzodiazepine prescription is a growing phenomenon among the elderly population. However, information related to the frequency of these drugs among the elderly population attending in emergency departments (ED) and its impact over prognosis is scarce. The aim of this study is to assess the prevalence of benzodiazepine prescription and to analyze its association with short‐term prognosis in elderly patients attended in ED. Methods A retrospective analysis of the EDEN (Emergency Department Elderly in Need) cohort was conducted. This registry included all elderly patients attending in 52 Spanish EDs for any condition, between April 1st and 7th in 2019. Socio‐demographic data, comorbidities, and medication were recorded by consulting the patient's electronic health records. The assessed outcomes consisted on new ED visit, hospitalization, and mortality at 30 days after the first ED visit, associated with the use of benzodiazepines at baseline in comparison with no prescription of benzodiazepines. Crude and adjusted logistic regression analyses including patient's comorbidities were performed. Two sensitivity analyses were performed considering concomitant prescription of other central nervous system depressants as well as direct discharge from the ED. Results 25 557 patients were evaluated (mean age 78 [IQR: 71–84]). 7865 (30.8%) patients were taken benzodiazepines at admission. After adjustment for comorbidities and other central nervous system drugs, benzodiazepine prescription was associated with ED revisit [OR: 1.10 (95%CI: 1.03–1.18)]. Similar results were found in the sensitivity analysis, eliminating patients with central nervous depressors [OR: 1.11 (1.03–1.25)] and patients discharged to home [OR: 1.13 (1.04–1.23)]. No association was found between the use of these drugs and new hospitalizations [OR: 0.90 (0.77–1.05)] or mortality 30 days after discharge [OR: 1.01 (0.88–1.18)]. The results held for all three outcomes in the sensitivity analyses. Conclusion The use of benzodiazepines is a frequent phenomenon among the elderly population attended in the ED, being associated with an increased risk of new visits to the emergency room, but not with an increased risk of 30‐day hospitalization or mortality.
pharmacology & pharmacy,public, environmental & occupational health